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Systematic reviewAbstract Objectives: to elucidate the association between HHVs [Human Herpes Viruses–human
cytomegalovirus (HCMV), Epstein–Barr virus (EBV) and herpes simplex virus (HSV)] and risk of
aggressive periodontitis (AgP) and advanced periodontitis (AP). Materials and methods: the
addressed focused question was: ‘‘Is there an association between HHVs and AgP and do HHVs
implicate in the pathogenesis of AgP and AP?” Electronic search of the MEDLINE/PubMed,
EMBASE, Scopus, ISI Web of knowledge, and Google-Scholar databases was combined with hand
searching of articles published from 1970 up to and including March 2016 using relevant MeSH
terms. Review papers, in-vitro and experimental studies, case reports, commentaries, interviews,
updates and duplicate publications were excluded. Results: twelve studies were included. Three
studies reported elevated percentage of HSV1 carriage in AgP patients whereas two studies reported
comparable percentage levels of HSV1 among AgP patients and periodontally healthy patients.
Seven studies reported significantly higher percentage levels of HCMV in AgP patients as compared
to healthy controls whereas four studies showed comparable levels of HCMV among AgP and
healthy controls. Six studies reported higher EBV carriage in AgP patients than healthy controls
whereas five studies showed comparable EBV percentage levels among AgP and periodontally
healthy patients. Conclusion: overall, human herpes virus (HSV, CMV and EBV) levels are
increased and are found to be associated with AgP and AP as compared to healthy individuals.
However a possible involvement of HHVs in the pathogenesis of AgP warrants further investiga-
tion.
 2016 The Author. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).rnal for
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1.1. Rationale
Aggressive periodontitis (AgP) is a rapidly progressive peri-
odontal disease in adults associated with limited amount of
dental plaque, in otherwise systemically healthy individuals.1
The etiopathogenesis of AgP involves multifactorial risk fac-
tors such as immunologic, genetic, and environmental factors.
The current understanding of the pathogenesis of AgP suggests
that it is associated with anaerobic gram-negative pathogenic
bacteria such as Aggregatibacter actinomycetemcomitans (Aa),
Prevotela interdemia and Porphyromonas gingivalis (Pg).2,3
However, several studies have reported that deep periodontal
pockets are also associated with human herpesviruses (HHVs)
and may be the source of periodontal tissue destruction.4–7
Human herpesviruses are a group of enveloped DNA
viruses which belong to the family herpesviridae. The most
common types of HHVs affecting humans are herpes simplex
virus (HSV) type 1 and 2; cytomegalovirus (CMV); and
Epstein–Barr virus (EBV).8 Aggressive periodontitis patients
are associated with a state of elevated localized inflammatory
burden due to increased gingival crevicular fluid cytokine
levels.9 Herpesvirus infection is thought to stimulate local
cytokine production through macrophages and other inflam-
matory cells which may lead to the impairment of local peri-
odontal immune defense.10
Herpesviruses target host cells by attachment onto the cell
surface through glycoproteins present in the viral envelope.11
A number of studies suggest that HHVs are associated with
clinical periodontal parameters in AgP.12–14 These viruses with
bacteria, may be implicated in causing periodontal destruction.cite this article in press as: Alzahrani AA Association between human herpes
Research (2016), http://dx.doi.org/10.1016/j.sjdr.2016.06.004In this context, it may be hypothesized that the subgingival
carriage of herpesvirus in patients affected by AgP should be
elevated as compared to periodontally healthy individuals
and may be implicated in causing the disease. Moreover, what
drives these viruses for causing AgP is still unclear. In the past
decade, a number of microbiological studies have been con-
ducted to elucidate the role of HHVs in the pathogenesis of
AgP and advanced periodontal lesions.7,15 The present study
is designed to clarify the periodontopathogenic role of HHVs
in AgP and advanced periodontitis (AP).
1.2. Objective
Therefore, the aim of the present study was to elucidate the
association between HHVs [Human Herpes Viruses–human
cytomegalovirus (HCMV), Epstein–Barr virus (EBV) and her-
pes simplex virus (HSV)] and risk of AgP and AP.
2. Materials and methods
2.1. Focused question
This review was registered at the National Institute for Health
Research PROSPERO, International Prospective Register of
Systematic Reviews, registration number CRD42015013792.
Based on the Preferred Reporting Items for Systematic Review
and Meta-Analysis (PRISMA) guidelines,16 a specific question
was constructed. The addressed focused question was ‘‘Is there
an association between HHVs and AgP and do HHVs
implicate in the pathogenesis of AgP and AP?”
PECO Question (Patient, Exposure, Comparative,
Outcome)virus and aggressive periodontitis: A systematic review, The Saudi Journal for
Figure 1 Preferred Reporting Items for Systematic Review and Meta Analyses (PRISMA) flow diagram.
Association between human herpes virus and aggressive periodontitis 3(P) Patients in the included studies must have aggressive
and/or advanced periodontitis.
(E) HHVs (HCMV, EBV, and HSV).
(C) Periodontally healthy control.
(O) Outcome presented as percentage values of HHVs.
2.2. Eligibility criteria
The following eligibility criteria were entailed: case-control
studies; cross-sectional studies; patients with AgP and/or AP
versus healthy controls; in-vivo studies evaluating the associa-
tion between herpes viruses and AgP; studies reporting preva-
lence of one or more human herpes viruses such as HCMV,
EBV or HSV in subgingival plaque samples as outcome;
studies evaluating periodontal active sites and stable sitesPlease cite this article in press as: Alzahrani AA Association between human herpes
Dental Research (2016), http://dx.doi.org/10.1016/j.sjdr.2016.06.004within AgP patients only; studies published in English lan-
guage only.
The exclusion criteria included; review papers, in-vitro and
experimental studies, case reports, commentaries, interviews,
updates and duplicate publications.
2.3. Data sources
The author (AAA) searched the MEDLINE/PubMed,
EMBASE, Scopus, ISI Web of knowledge, and Google-
Scholar databases from 1970 up to and including March
2016 for appropriate articles addressing the focused question.
A structured approach to literature searching was used to iden-
tify the relevant papers that report the prevalence of HHVs in
AgP patients. Reference lists of original studies were handvirus and aggressive periodontitis: A systematic review, The Saudi Journal for
Table 1 Characteristics of the included studies.
Author et al., year Study design;
population
Sample size;
percentage female
Mean age in
years (range)
Study groups Mean Pocket depth Mean Clinical
attachment level
Main outcomes
Test (n) Control
(n)
Sharma et al.,17 2015 Cross-
sectional;
India
30; 50% AgP; 23.3
Control; 24.9
(NA)
15 15 NA NA – HCMV was significantly higher in AgP group
than healthy controls
– EBV was comparable among both the groups
Dani et al.,18 2013 Cross-
sectional;
India
30; 43% AgP; 27.27
Control; 23.13
(18–30)
15 15 AgP: 3.56 ± 1.12
Control: 1.36 ± 0.19
AgP: 2.33 ± 1.40
Control: –
– EBV was significantly higher in AgP group than
healthy controls
– HSV1 and HCMV were comparable among both
groups
Das et al.,19 2012 Cross-
sectional;
India
10y; 60% NA (18–55) 25
active
sites
25
healthy
sites
NA NA – HSV1 and EBV were significantly higher in AgP
group than in controls
– HSV2 and HCMV were comparable among both
groups
Sharma et al.,20 2012 Case-control;
India
60; 48% AgP; 29.65
Control; 36.52
(20–45)
20 20 AgP: 8.91 ± 0.93
Control: 0.75 ± 0.56
AgP: 8.32 ± 0.96
Control: –
Both HCMV and EBV were significantly higher in
AgP groups than healthy controls
Botero et al.,21 2007 Case-control;
Colombia
52; 69% AgP; 24.3
Control; 31.2
(NA)
10 22 AgP: 4.24 ± 0.42
Control: 2.55 ± 0.32
AgP: 3.97 ± 0.46
Control: 2.52 ± 0.3
– HCMV was significantly higher in AgP than
healthy controls
Imbronito et al.,7
2008
Case-control;
Brazil
120; 61% AgP; 27.3
Control; 28.1
(NA)
30 30 AgP: 4.3 ± 0.4
Control: 2.0 ± 0.2
AgP: 4.8 ± 0.4
Control: 2.1 ± 0.2
– HSV1 and EBV were significantly higher in AgP
group than in controls
– HCMV was comparable among both groups
Kamma et al.,22
2001
Cross-
sectional;
Greece
16y; 44% 33.1; (NA) 32
active
sites
32
healthy
sites
Active sites: 6.8
± 1.6 Stable sites:
5.6 ± 1.3
Active sites: 6.9
± 1.4 Stable sites:
5.6 ± 1.6
– HCMV was significantly higher in active sites
than stable sites in AgP group
– HSV§ and EBV were comparable among both
active and stable sites in AgP
Nibali et al.,24 2009 Case-control;
United
Kingdom
140; 59% AgP; 33.5
Control; 50.3
(NA)
80 40 LAgP: 3.5 ± 0.6
GAgP: 4.0 ± 0.9
Control: 2.7 ± 1.0
LAgP: 3.8 ± 0.5
GAgP: 4.2 ± 1.0
Control: 2.7 ± 1.1
– EBV was comparable among AgP and healthy
controls
– HCMV was not detected in any group
Saygun et al.,23 2004 Cross-
sectional;
Turkey
34; 50% AgP; 24.1
Control; 24.1
(17–31)
18 16 AgP: 5.0 ± 1.1
Control: 2.1 ± 0.6
AgP: 5.1 ± 1.1
Control: 2.1 ± 0.6
– HSV1, HCMV and EBV were significantly
higher in AgP group than healthy controls
– HSV2 was comparable among both groups
Stein et al.,15 2013 Cross-
sectional;
Germany
130; 57% AgP; 24.1
Control; 24.1
(23–70)
65 65 AgP: 5.8 ± 1.2
Control: 2.8 ± 0.3
AgP: 6.7 ± 1.6
Control: 3.1 ± 0.5
– HSV1, EBV and HCMV were comparable
among both groups
Ting et al.,12 2000 Cross-
sectional;
United States
11y; 63% NA (10–23) 3 active
sites
3
gingivitis
sites
NA NA – HCMV was significantly higher in AgP group
than healthy controls
– HSV§, EBV 1 and 2 were comparable among
AgP and control groups
Yapar et al.,13 2003 Prospective;
Turkey
33; 42% AgP; 24.05
Control; 24.12
(17–31)
17 16 AgP: 5.08 ± 1.07
Control: 1.71 ± 0.39
AgP: 5.04 ± 1.13
Control: 1.71 ± 0.39
– EBV and HCMV were significantly higher in
AgP group than healthy controls
AgP; aggressive periodontitis, HSV; herpes simplex virus, HCMV; human cytomegalovirus, EBV; Epstein–Barr virus, NA; not available.
§ Type of HSV not specified.
y Split-mouth technique having test and control periodontal sites in same subjects.
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Association between human herpes virus and aggressive periodontitis 5searched to identify any articles that could have been missed
during the initial search. Hand searching of the following
journals was performed: Journal of Clinical Periodontology,
Journal of Periodontology, Journal of Periodontal Research,
Journal of Oral Science, Journal of International Oral Health,
Brazilian Oral Research, and Indian Journal of Dental
Research. Electronic database searches were performed using
different combinations of Medical Subject Headings (MeSH)
terms and free text words: (human herpes virus OR HHV
OR herepesviridae OR cytomegalovirus OR CMV OR HCMV
OR Epstein–Barr virus OR EBV OR herpes simplex virus OR
HSV OR simplex virus OR herpes virus 4) AND (Aggressive
periodontitis OR advanced periodontitis OR periodontitis
OR periodontal disease OR juvenile periodontitis OR early-
onset periodontitis).
2.4. Screening methods and data abstraction
Titles and abstracts of articles that satisfied the selection pro-
tocol were screened by the author and checked for agreement.
The information from the accepted studies was tabulated
according to the (1) study design, (2) demographic characteris-
tics of the participants, (3) sampling types (4) sampling meth-
ods (5) microbiological analysis (6) herpesviruses prevalence
and (7) main outcomes.
3. Results
3.1. Study selection
The search protocol is presented in Fig. 1. A total of 42 studies
were initially identified. After screening of the titles and
abstracts, 30 papers were excluded and a total of 12
papers7,12,13,15,17–24 were included in the systematic review
(Table 1). All studies7,12,13,15,17–24 were performed at either
universities or health care centers. Fig. 1 shows the study iden-
tification flow with the reasons for exclusion of articles.
3.2. General characteristics of the studies included
Twelve studies7,12,13,15,17–24 included in the present review
enlisted seven cross-sectional studies12,15,17–19,22,23, four case-
control studies7,20,21,24 and one prospective intervention
study13 (Table 1). The total number of participants in the
included studies ranged between 1018 and 14023 individuals
with mean age ranging between 23.1318 and 50.324 years. All
the included studies7,12,13,15,17–24 reported percentage of female
participants, which ranged between 42%13 and 69%21 individ-
uals. The number of AgP patients ranged from 1021 and 8024
whereas healthy control patients ranged between 1517,18 and
6515 individuals respectively. The mean pocket depth (PD)
and clinical attachment level (CAL) in AgP patients ranged
from 3.5 ± 0.6 to 8.91 ± 0.93 and 2.33 ± 1.4 to 8.32 ± 0.96
respectively. All studies7,12–14,16–23 collected subgingival plaque
samples either with the help of curette13,17–20,23,24 or paper
points.7,12,15,21,22 Three types of herpesviruses including
HSV, HCMV and EBV were studied in all the included stud-
ies.7,12,13,15,17–24 All studies7,12,13,15,17–24 employed polymerase
chain reaction (PCR) technique for the detection of her-
pesviruses (see Table 2).Please cite this article in press as: Alzahrani AA Association between human herpes
Dental Research (2016), http://dx.doi.org/10.1016/j.sjdr.2016.06.0043.3. Main outcomes of the included studies
3.3.1. Herpes simplex virus
Seven7,12,15,18,19,22,23 out of 12 studies included7,12,13,15,17–24
evaluated the percentage levels of HSV in AgP and periodon-
tally healthy controls. Three studies7,19,23 reported elevated
percentage of HSV1 carriage in AgP patients whereas two
studies15,18 reported comparable percentage levels of HSV1
among AgP patients and periodontally healthy patients. Two
studies19,23 showed comparable percentage levels of HSV2
among AgP patients and healthy controls. HSV1 in AgP and
periodontally healthy patients ranged from 1.5% to 86.7%
and 0% to 20% respectively whereas, HSV2 in AgP and
healthy controls ranged from 8% to 16.7% and 0% to 4%
respectively.
Two studies12,22 reported prevalence of HSV in AgP and
healthy controls without differentiated into type 1 and type 2.
3.3.2. Cytomegalovirus
All the studies evaluated the percentage levels of HCMV in
AgP patients and healthy controls. Seven studies reported sig-
nificantly higher percentage levels of HCMV in AgP patients
as compared to healthy controls whereas four studies showed
comparable levels of HCMV among AgP and healthy controls.
One study did not detect HCMV in either groups. The percent-
age levels of HCMV in AgP and healthy controls ranged from
0% to 72.7% and 0% to 56.7% respectively.
3.3.3. Epstein–Barr virus
Epstein–Barr virus was studied in overall eleven stud-
ies.7,12,13,15,17–20,22–24 Six studies7,13,18–20,23 reported higher
EBV carriage in AgP patients than healthy controls whereas
five studies12,15,17,22,24 showed comparable EBV percentage
levels among AgP and periodontally healthy patients. The per-
centage levels of EBV in AgP and healthy controls ranged
from 7.5% to 72.2% and 0% to 18.1% respectively.
3.3.4. Advanced periodontitis
Advanced periodontitis lesions are comprised of deep pocket
depthsP 6mm. Deep pockets were associated with prevalence
of HHVs in advanced form of lesions. Subjects with advanced
form of periodontitis were seen in three studies.15,20,22 The
mean pocket depth ranged from 6.8 mm to 8.9 mm.
4. Discussion
The present study was based on the hypothesis that HHVs
including, HSV1, HSV2, CMV and EBV levels would be sig-
nificantly raised in AgP patients as compared to individuals
with healthy periodontium. Overall, the levels of HHVs were
raised in AgP as compared to healthy subjects in the studies
reviewed.7,12,13,15,17–24 The results of this study is corroborated
by previous literature review by Rodrigues et al.14 which
showed positive association between HHVs and AgP.
Aggressive periodontitis is characterized by early onset, rapid
periodontal tissue destruction and little presence of plaque.
Although specific pathogens including Fusobacterium nuclea-
tum (Fn), Pg and Aa are implicated in its pathogenesis, it is
unlikely that a small group of bacteria are responsible for this
heterogeneous disease.25 The simultaneous occurrence ofvirus and aggressive periodontitis: A systematic review, The Saudi Journal for
Table 2 Microbiological parameters of the included studies.
Author et al.,
year
Type of
sample
Sampling
method
Microbiological
analysis
Sampled
site
Herpesviruses Prevalence (%)
HSV(+) HCMV(+) EBV(+)
Test Control Test Control Test Control
Sharma et al.,17
2015
Subgingival
plaque
Curette Hotstart PCR NA NA NA 46.67* 6.67 40.0 6.67
Dani et al.,18
2013
Subgingival
plaque
Curette Multiple PCR NA HSV1 = 47.0 HSV1 = 13.0 53.0 20.0 67.0* 7.0
Das et al.,19 2012 Subgingival
plaque
Curette Multiple PCR P6 mm
PD
HSV1 = 80*
HSV2 = 8
HSV1 = 12
HSV2 = 4
12.0 8.0 32* 8.0
Sharma et al.,20
2012
Subgingival
plaque
Curette PCR NA NA NA 45.0* 10.0 45* 0
Botero et al.,21
2007
Subgingival
plaque
Paper point Nested PCR NA NA NA 40* 18.1 NA NA
Imbronito et al.,7
2008
Subgingival
plaque
Paper point Nested PCR NA HSV1 = 86.7* HSV1 = 20.0 60.0 56.7 33.3* 0
Kamma et al.,22
2001
Subgingival
plaque
Paper point Nested PCR NA 34.4 9.4 59.4* 12.5 43.8 12.5
Nibali et al.,24
2009
Subgingival
plaque
Curette Real-time PCR P5 mm
PD
NA NA 0 0 7.5 10.3
Saygun et al.,23
2004
Subgingival
plaque
Curette PCR 7–10 mm
PD
HSV1 = 77.8*
HSV2 = 16.7
HSV1 = 0
HSV2 = 0
72.2* 0 72.2* 6.3
Stein et al.,15
2013
Subgingival
plaque
Paper point Real-time PCR NA HSV1 = 1.5 HSV1 = 1.5 1.5 1.5 10.8 13.9
Ting et al.,12 2000 Subgingival
plaque
Paper point Nested PCR 5–11 mm
PD
54.5 9.09 72.7* 18.18 EBV1 = 63.6
EBV2 = 9.09
EBV1 = 18.1
EBV2 = 0
Yapar et al.,13
2003
Subgingival
plaque
Curette PCR 5–10 mm
PD
NA NA 64.7* 0 70.6* 6.3
* Statistically significant, PCR; polymerase chain reaction, HSV; herpes simplex virus, HCMV; human cytomegalovirus, EBV; Epstein–Barr virus, NA; not available.
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Association between human herpes virus and aggressive periodontitis 7HHVs along with Pg and Aa, has led investigators to believe
that HHVs influence the occurrence and extent of AgP. It is
therefore, suggested that herpes virus infection along with
the inflammatory response triggers periodontal tissue destruc-
tion in periodontal disease. The release of pro-inflammatory
cytokines potentially activate matrix metalloproteinase and
osteoclasts causing the pathogenesis of periodontal disease.26
Interestingly, in six12,15,18,19,22,23, four7,15,18,19 and
five12,15,17,22,24 studies, included in the present review, HSV,
CMV and EBV were found to have comparable levels among
sub gingival plaque of AgP and healthy subjects respectively.
Multiple explanations can be presented in this regard. It has
been suggested that paper points when utilized for sample col-
lection fail to collect enough sample from the apical parts of
the pockets, where viruses are expected to be in abundance.27
By contrast sample collection through curettes provide plaque
from the entire pocket. In the present review, five stud-
ies7,12,15,21,22 used paper points for collection of plaque samples
for assessment of viruses. This could have possibly affected the
outcomes in these studies.7,12,15,21,22 In addition, the type of
PCR testing has a potential influence on the detection of viral
strains. It is reported that nested PCR testing is highly sensitive
as compared to real time PCR in detecting viruses including
CMV. In a study comparing nested with real time PCR, it
was concluded that real time PCR may have provided an
underestimation of viral presence.28,29 Moreover, nested PCR
being highly sensitive has resulted in increased numbers of
viruses detection.7,12,21,22 However other studies using methods
including identification of 100 genome copies, have shown low
levels of viruses.28,30 In addition both the nested and real time
PCR fail to inform about the latency of the viruses, as viral
infections tend to have asymptomatic and active phases of dis-
ease.29 It is noteworthy, that four7,12,21,22, two15,24 and two18,19
studies in the present review, used nested, real time and multi-
ple PCR respectively, for viral strain detection. Hence, hetero-
geneity in methodology of the included studies could have
resulted in the comparable levels of HHV among the studies
reviewed.7,12,13,15,17–24 Therefore, further studies with stan-
dardized methodology, using sensitive, specific, robust and
reproducible viral detection process for the identification of
HHVs in subjects with AgP are recommended.
Interestingly, the prevalence range of CMV, HSV and EBV
in AgP subjects as reviewed from the included stud-
ies7,12,13,15,17–24 were 0% to 72.7%, 1.5% to 86.7% and 7.5%
to 72.2% respectively. These variations in the frequency of
HHVs makes it challenging to correlate the presence of partic-
ular viruses (HSV, CMV, EBV) to the disease process of AgP.
A possible explanation for these findings could be related to
latency in herpes virus infections and the disease activity of
the plaque sample sites. It has been reported that higher
HHV frequency were found in active periodontal disease pock-
ets as compared to stable sites.23 In the present review, the
mean periodontal pocket depth values among the included
studies in AgP patients ranged from 3.5 to 8.9 mm, eluding
to the fact that the disease activity among the subjects varied
considerably. This is a possible reason for the wide variations
of HHV frequencies among the studies reviewed.7,12,13,15,17–24
In addition, difference in ethnicity and population subgroup
may also explain the heterogeneity in the data reported. In
the present review, HHV prevalence among the included
studies was reported in multiple populations, including,Please cite this article in press as: Alzahrani AA Association between human herpes
Dental Research (2016), http://dx.doi.org/10.1016/j.sjdr.2016.06.004subjects from Europe, America, Africa, South America and
the Indian subcontinent. It is suggested that the distribution
of genotype and prevalence of HHV in serum differs among
different populations.18,31 Immune response to viral antigens
is dependent on t-cell recognition. This process depends on
presentation of antigen peptide by MHC (major histocompat-
ibility complex) molecules. MHC polymorphism is ethnically
influenced and therefore could influence the susceptibility
toward HHV.15,32 Therefore, it is clear that the susceptibility
of different populations for HHV would influence the fre-
quency of these viruses in AgP subjects.
In the studies reviewed, it has been emphasized that the
periodontal destruction in AgP patients is the outcome of a
HHV and bacterial co-infection.17,22 HHV infection has the
ability to impair host defense response by altering the func-
tion of chronic inflammatory and immune cells, including,
macrophages, polymorphonuclear neutrophils, leukocytes
and lymphocytes.10,33 In addition it is proposed that a mixed
HHV infection can disrupt protective epithelial barriers, facil-
itating bacterial infiltration and attachment.34 This theory can
be supported by explanations, that HHV co-infection with
different bacteria has been observed in systemic diseases
including pulmonary infections, inflammatory bowel disease,
and otitis media.35 In addition, periodontal sites with co-
infection of bacteria and HHV show rapid and progressive
(active) periodontal destruction.22 Therefore, poorly function-
ing immune cells along with a weak epithelial barrier serve to
augment the virulence of AgP bacterial pathogens including,
Pg, Aa and Fn.
In summary, the data reviewed predict a possible influence
of HHV co-infection in the progress of periodontal tissue loss
in AgP patients. The HHV-bacterial association in periodonti-
tis proposes that active HHV infection induces periodontal
destruction and that inflammatory host-immune responses
against the HHV infection are an important component of
the etiopathogenesis of AgP. Therefore, studies identifying
the effect of eradication of HHV levels for prevention and
arrest of disease are recommended.
5. Conclusions
Overall, human herpes virus (HSV, CMV and EBV) levels are
increased and are found to be associated with AgP and AP as
compared to healthy individuals. However a possible involve-
ment of HHVs in the pathogenesis of AgP warrants further
investigation.
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